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ABSTRACT
The HSF and FOXO families of transcription fac-
tors play evolutionarily conserved roles in stress
resistance and lifespan. In humans, the rs2802292
G-allele at FOXO3 locus has been associated with
longevity in all human populations tested; more-
over, its copy number correlated with reduced fre-
quency of age-related diseases in centenarians. At
the molecular level, the intronic rs2802292 G-allele
correlated with increased expression of FOXO3, sug-
gesting that FOXO3 intron 2 may represent a reg-
ulatory region. Here we show that the 90-bp se-
quence around the intronic single nucleotide poly-
morphism rs2802292 has enhancer functions, and
that the rs2802292 G-allele creates a novel HSE bind-
ing site for HSF1, which induces FOXO3 expres-
sion in response to diverse stress stimuli. At the
molecular level, HSF1 mediates the occurrence of
a promoter–enhancer interaction at FOXO3 locus in-
volving the 5′UTR and the rs2802292 region. These
data were confirmed in various cellular models in-
cluding human HAP1 isogenic cell lines (G/T). Our
functional studies highlighted the importance of the
HSF1-FOXO3-SOD2/CAT/GADD45A cascade in cel-
lular stress response and survival by promoting ROS
detoxification, redox balance and DNA repair. Our
findings suggest the existence of an HSF1-FOXO3
axis in human cells that could be involved in stress
response pathways functionally regulating lifespan
and disease susceptibility.
INTRODUCTION
Cellular homeostasis is dependent upon the interaction be-
tween genes and the environment, and relies on the coordi-
nated regulation of interlinked molecular processes includ-
ing stress resistance. The ability to resist to cellular stress
has been associated with good health and longevity and re-
quires the concerted action of pathways involved in antiox-
idant defense, heat protection, protein degradation, glyco-
gen storage, DNA repair and metabolism. These pathways
ultimately lead to the activation of stress resistance tran-
scription factors, such as HSF1 and FOXO3 (1,2), which in
turn regulate interconnected gene expression networks that
are evolutionarily conserved from yeast to mammals (3,4).
HSF1 coordinates the transcription of stress-induced
genes to ensure adaptation of eukaryotic cells and organ-
isms to environmental changes. Although its pivotal role in
cellular homeostasis has been mainly linked to the trans-
activation of genes encoding heat shock proteins, recent
genome-wide studies have revealed that HSF1 can repro-
gram gene expression more extensively, being involved both
in physiological processes, including metabolism and ag-
ing, and pathological conditions, such as neurodegenera-
tive diseases and cancer. Specifically, HSF1 plays a key role
in the regulation of core cellular processes in cells under
stress – where it controls genes encoding for transcription
factors, cell-cycle regulators and components of the trans-
lational apparatus – and allows for reactivation of the cel-
lular machinery upon restoration of conditions compatible
with proliferation (5). Indeed, it has been shown that HSF1
regulates cellular response to oxidative stress, hypoxia and
metabolic imbalance (6–9), and is required together with
FOXO3 to sustain lifespan extension in model organisms
(4).
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FOXO3 belongs to the FOXO family of transcription
factors, which share the FHRE DNA consensus sequence.
FOXO3 controls the expression of a complex network of
genes regulating proliferation, survival, metabolism and au-
tophagy, ultimately leading to tumor suppression, nutrient
sensing and stress resistance in several cell types and tis-
sues. In multicellular organisms, FOXO proteins have been
involved in the regulation of response to oxidative stress,
starvation and caloric restriction with the final effect of in-
creasing lifespan and prevent aging-related diseases, such as
diabetes and cancer (10).
The human FOXO3 gene comprises four exons and three
introns, but only exon 2 and 3 are actively transcribed and
translated into FOXO3 protein (see Figure 1A). Intrigu-
ingly, intron 2 is very large (101 625 bp) and contains a
p53 binding site which is able to activate FOXO3 expres-
sion in response to DNA damage (11). Furthermore, sev-
eral single nucleotide polymorphisms (SNPs) were charac-
terized in this intron and used for association studies with
longevity and age-related diseases in humans. Importantly,
all the previously reported FOXO3 coding variants failed to
show any role in longevity (12). Of note, among non-coding
SNPs the rs2802292 minor allele (G), located at intron 2,
has been shown to be strongly associated with long-lived
subjects in all human populations tested (13–20) (collec-
tively 5746 subjects>90 years of age and 6554 controls – see
Supplementary Table S1), and its copy number correlated
well with healthy aging phenotypes and lower prevalence of
age-related diseases (13).We recently showed that an inverse
correlation exists between rs2802292 G-allele copy number
and cancer risk in patients with hamartomatous polyposis
syndromes that are caused by mutations in STK11 (Peutz-
Jeghers syndrome) or PTEN (PTEN hamartoma tumor
syndrome) (21), two genes whose protein products are prox-
imate upstream regulators of FOXO3 (10). At the molec-
ular level, preliminary data seem to indicate that the in-
tronic rs2802292G-allele correlates with increased basal ex-
pression of FOXO3 (21,22), suggesting the hypothesis that
FOXO3 intron 2 may act as a regulatory region.
Here, we show that the 90-bp sequence around the in-
tronic SNP rs2802292 at FOXO3 locus has enhancer prop-
erties, and that HSF1 binding to this region through a novel
HSE binding site created by the rs2802292 minor G-allele
promotes expression of FOXO3 in response to diverse stress
stimuli. Molecular analyses carried out in various estab-
lished cell lines, primary cultures and human near-haploid
HAP1 isogenic cells (G/T) generated by the CRISPR/Cas9
system for genome editing revealed that HSF1 mediates
the occurrence of physical and functional interactions be-
tween the 5′UTR and the rs2802292 region at FOXO3 locus
thereby activating their enhancer functions. At last, we per-
formed functional studies showing that the identified regu-
latory intronic region is involved in cellular stress response
and lifespan regulation.
MATERIALS AND METHODS
Cell lines, primary culture of biopsies and reagents
HEK-293 and OVCAR-3 cells (both from ATCC)
were grown in Dulbecco’s modified Eagle’s medium
(DMEM) (Gibco, 11966025), HAP1 FOXO3 SNP
rs2802292 (G to T) and HAP1 parental (G) cell lines
(from Invitrogen GeneArt Engineered Cell Models Col-
lection, ID HZGHK481 and ID C631, respectively)
were grown in Iscove’s Modified Dulbecco’s medium
(IMDM) (Gibco, 12440-053), supplemented with 10%
Fetal Bovine Serum (FBS) (Gibco, 25030081), 100 IU/ml
penicillin and 100 g/ml streptomycin (Gibco, 15140122),
2 mM L-glutamine (HEK-293) (Gibco, 25030081) and
1% non-essential amino acids in Medium Essential
Medium (MEM) solution (HEK-293) (Gibco, 11140035).
Lymphoblastoid cell lines and primary dermal fibrob-
lasts are archival samples from the UOC Laboratory of
Medical Genetics at the University of Bari ‘Aldo Moro’.
Lymphoblastoid cell lines were generated by transforma-
tion with Epstein–Barr virus (23) of peripheral B lympho-
cytes derived from centenarian donors (≥100 years). Pri-
mary dermal fibroblasts were obtained from skin biopsies of
healthy donors (24). All donors signed a regular informed
consent for research purposes approved by the local Ethics
Committee (AOU Policlinico, 70124 Bari, Italy) in compli-
ance with international and national data protection laws.
Lymphoblastoid cell lines and human primary dermal fi-
broblasts were grown in Roswell Park Memorial Institute
(RPMI) 1640 medium (Gibco, 11875-093) supplemented
with 10% FBS, 2 mM L-glutamine, 100 IU/ml penicillin
and 100 g/ml streptomycin. All cell lines were maintained
at 37◦C and 5% CO2 avoiding confluence at any time.
Human primary fibroblasts were used for experiments at
the second passage. KRIBB11 (Calbiochem, 385570) was
purchased from Merck. H2O2 (H1009) and Menadione
(M2518) were purchased from Sigma.
CRISPR/Cas9-mediated genome editing
HAP1FOXO3SNP rs2802292 (G toT) cells were generated
by a GeneArt Engineered Cell Model service based on the
near-haploid human cell line HAP1 using CRISPR/Cas9-
mediated genome editing. Briefly, a double strand break is
introduced by targeting the CRISPR/Cas9 to a specific site,
in the presence of a suitably designed homologous donor
sequence. gRNAs and oligo donor sequences used for engi-
neering are available from the authors upon request.
Genotyping
Genomic DNA from cell lines and primary fibroblasts was
extracted using QIAsymphony SP/AS instruments (QIA-
GEN) according to the manufacturer’s protocol and quan-
tified on a NanoDROP 2000 spectrophotometer (Thermo
Scientific). Polymerase chain reactions (PCRs) were car-
ried out in 25 l reaction mixtures containing 50 ng of ge-
nomic DNA, 1× PCR buffer (Tris–HCl, (NH4)2SO4, 15
mMMgCl2; pH 8.7), 200 M dNTPs (Thermo Fisher Sci-
entific, R0181) and 0.5 U Taq DNA Polimerase Recombi-
nant (Thermo Fisher Scientific, EP0405) and the follow-
ing primers (10 pmol each): FOXO3 rs2802292g/t Fw and
FOXO3 rs2802292g/t Rv. PCR amplification cycles were
carried out at 95◦C for 15 min followed by 29 cycles of
denaturation at 94◦C for 1 min, annealing at 60◦C for 1
min and extension at 72◦C for 1 min, and by a final ex-
tension at 72◦C for 10 min on a GeneAmp PCR System
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Figure 1. The rs2802292 locus has enhancer properties and the presence of the G-allele creates a unique binding site for HSF1, which is required for
transcriptional activation. (A) Top: structure of the human FOXO3 gene. The four exons are shown as white (non-coding) or dark (coding) boxes. Bottom:
schematic representation of the luciferase constructs generated. (B) Expression levels of FOXO3 exon 2 and 3, as measured by quantitative PCR (qPCR)
in cell lines established from centenarians that were homozygous for the rs2802292 T-allele (TT, n = 3), heterozygous (TG, n = 3) or homozygous for the
rs2802292 G-allele (GG, n= 3). (C) Luciferase reporter assays (n= 3) measuring the enhancer activity of the indicated constructs in HEK-293 cells. Along
the y-axis, relative luciferase units (RLU) are normalized to Renilla luciferase signal. (D) HSF1 recognition motif identified in the rs2802292 SNP minor
G-allele. (E) Enhancer activity of the indicated constructs in the presence or absence of exogenous MYC-tagged-HSF1, as assessed by luciferase reporter
assays (n = 3) in HEK-293 cells. (F) Luciferase reporter assays (n = 3) measuring the effect of HSF1 silencing by siRNAs on the enhancer activity of
the indicated constructs. siNC, siRNA negative control. Two different siRNAs for HSF1 (siHSF1-1 and siHSF1-2) were tested. The presented results are
representative of at least three independent experiments. P-values were derived from t-tests: *P ≤ 0.05.
9700 thermocycler (Applied Biosystems). A total of 5 l of
the amplified products were loaded onto 2% Agarose Stan-
dard Low EEO (Sigma, A9539) in 0.5× Tris-Borate-EDTA
(TBE) (Serva, 39320.01) and visualized using GelRed™ (Bi-
otium, 41003). Sequencing products were purified by use of
the DyeEx™ 2.0 Spin Kit (QIAGEN, 63206) and sequenced
on an ABI PRISM 310 Genetic Analyzer (Applied Biosys-
tems). Primer sequences are listed in ‘Additional Material’.
Quantitative real-time PCR
Total RNAs were extracted using TRI Reagent (Sigma,
93289). Samples were treated with DNase-1 (Ambion,
AM2222) and retro-transcribed using the Superscript Vilo
MasterMix (Invitrogen, 11755-050). PCRswere carried out
using the SsoAdvanced Universal SYBRGreen PCR Super
Mix (Biorad, 172–5272) on a CFX Connect™ Real-Time
PCR Detection System (Bio-Rad). Relative quantification
was done using the Ct method. Primer sequences are
listed in ‘Additional Material’.
Immunoblotting
Immunoblots were carried out as previously described (25).
A total of 20 g of protein extracts from each sample
were denatured in 4× Laemmli sample buffer (Biorad,
161–0747) and loaded into a Sodium dodecyl sulphate-
polyacrylamide gel for immunoblot analysis. Immunoblots
were performed using anti-ACTB (Sigma, A2066), anti-
HSF1 (Cell Signaling, 4356), anti-MYC Tag (Cell Signal-
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ing, 2278), anti-HSPA1A (Cell Signaling, 4872) and anti-
FOXO3 (Cell Signaling, 2497). Immunoblots were devel-
oped with the ECL-plus chemiluminescence reagent (GE
Healthcare, RPN2232) according to the manufacturer’s in-
structions.
Cell transfection and RNA interference
Transient transfection experiments were performed using
Lipofectamine 3000 (Thermo Fisher Scientific, L3000075)
according to the manufacturer’s instructions. A total of 500
ng of plasmid were used for transfection experiments. All
cell lines were transfected at 80% confluence and cultured
for an additional 48 h to express the plasmids before per-
forming the experiments.
For RNA interference, cells were transfected with 5 nM
siRNAs directed against HSF1 (siHSF1-1, Ambion, vali-
dated oligos AM16704; siHSF1-2, Stealth, D1016853) us-
ing Lipofectamine 3000. On-TARGET-plus control 5 nM
siRNAs (siNC, Thermo Scientific, D-001810-10-20) were
used as control sequences. siRNA sequences are listed in
‘Additional Material’.
Chromatin immunoprecipitation (ChIP)
Chromatin immunoprecipitation (ChIP) assays were per-
formed using the MAGnify Chromatin Immunoprecipita-
tion System (Thermo Fisher Scientific, 49–2024) as previ-
ously described (26). IgG antibodies were included in the kit
and anti-HSF1 (Abcam ChIP Grade, AB2923), anti-MYC-
tag (Cell Signaling, 2278), anti-histone H3-acetyl K27 (Ab-
cam ChIP Grade, AB4729), anti-histone H3-mono methyl
K4 (Abcam ChIP Grade, AB8895) antibodies were used
according to the manufacturer’s instructions. The set of
primers used for ChIP allows amplification of target regions
including HSF1 binding sites at intron 2 and at the 5′UTR
region of the locus. FOXO3 exon 3 region was used as a con-
trol (sequences are listed in ‘Additional Material’).
ChIP-loop assay
The ChIP-loop assay was carried out by combining the
ChIP procedure as previously described with the Chromo-
some Conformation Capture (3C) procedure as performed
by Gondor et al. (27). Briefly, chromatin was cross-linked
with paraformaldehyde 1% (Sigma, P6148) and digested
with Csp6I (Fermentas, ERO211) for the 3C step. Cross-
linked chromatin complexes were enriched by performing
a ChIP with anti-HSF1 antibodies (Abcam, ab2923). Im-
munoprecipitated complexes were resuspended in T4 ligase
buffer with 400 U of T4 DNA Ligase (NEB, MO202L).
Ligation mixes were subjected to reverse cross-link at 65◦C
overnight. Circular DNA was isolated with exonuclease
treatment, then purified with Qiagen PCR purification kit
(Qiagen, 28106) according to the manufacturer’s instruc-
tions and eluted with 50 l of 0.3× TE buffer containing
10 ng of Escherichia coli DNA. Ligated DNA was ampli-
fied with PhusionHigh-Fidelity DNAPolymerase (Thermo
Fisher Scientific, F530S) by performing 1 cycle at 98◦C for
30 s and 35 cycles at 98◦C for 10 s, 60◦C for 30 s and 72◦C
for 30 s, followed by 5 min at 72◦C. We used five different
couples of primers to analyze five possible ligation products.
Upon Csp6I digestion and ligation, we expected to obtain
specific PCR products using primers matching fragments
that could be in close proximity. Primer sequences are listed
in ‘Additional Material’.
Cloning
We constructed luciferase reporter plasmids by cloning
90 nucleotides located around the SNP into the pGL3-
Promoter Vector (Promega) upstream to the SV40 pro-
moter (Int2(s)5′-T, Int2(as)5′-T, Int2(s)5′-G) or down-
stream to the Luciferase gene (Int2(s)3′-T, Int2(as)3′-T).
Sequences were cloned in the antisense and sense orien-
tation relative to the SV40 promoter. For the Int2(s)5′-T,
Int2(as)5′-T, Int(s)5′-G plasmids, we introduced a KnpI site
at the 5′-end and a XhoI site at the 3′-end of the 90 nu-
cleotide sequences, after which we inserted them into a vec-
tor that was digested with KnpI and XhoI restriction en-
zymes (NEB, R0142S and R0146L, respectively). For the
Int2(s)3′-T, Int2(as)3′-T plasmids, we introduced a SalI site
at the 5′-end and a BamHI site at the 3′-end of the 90
nucleotide sequences, after which we inserted them into a
vector that was digested with SalI and BamHI restriction
enzymes (NEB, R0138L and R0136L, respectively). The
pGL3 plasmid without the enhancer region (BASIC) and
with the SV40 promoter alone (SV40) were used as con-
trols. A pcDNA-MYC-HSF1 mammalian expression clone
of human HSF1 and the pcDNA, PGL3 basic, pRL and
FHRE-Luc plasmids were all purchased fromAddgene. Se-
quences used for cloning are listed in ‘Additional Material’.
Luciferase assay
Cells were transfected into a 24-well plate with either the
empty vector (pcDNA) and/or the pcDNA-MYC-HSF1
expression constructs. After 24 h, cells were transfected
with the luciferase reporter plasmid. About 20–24 h af-
ter transfection, cells were washed with phosphate-buffered
saline and the mediumwas replaced with 100 l Passive Ly-
sis 1× (Promega, E1910) according to the manufacturer’s
instructions. Firefly and Renilla luminescence were mea-
sured with SPECTRO star Omega (BMG Labtech). Firefly
luciferase/Renilla luciferase ratios were calculated for each
well.
Assays for intracellular ROS levels
Intracellular Reactive Oxygen Species (ROS) levels were
evaluated with the Image-iT Live Green Reactive Oxygen
Species Detection Kit (Invitrogen, I36007) according to
the manufacturer’s instructions. Briefly, cells were stained
with 5-(and-6)-carboxy-2′,7′dichlorodihydrofluorescein di-
acetate (carboxy-H2DCFDA) for 30min and analyzed for
intracellular ROS levels under an Axio Observer Z1 fluores-
cence microscope (Zeiss). Zen Image software (Zeiss) was
used for quantitative analysis of fluorescent intensity. Back-
ground taken just outside the cells was subtracted from each
image.
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Cellular glutathione assay
The GSH/GSSG-Glo assay (Promega, V6611) was used to
measure the change in the redox state of the cells due to ox-
idants, which are downstream metabolites of O2−. The as-
say was performed according to the manufacturer’s instruc-
tions.
DNA damage assay
The DNA Damage Quantification Kit (Abnova, KA0784)
was used tomeasure the level of apurinic/apyrimidinic (AP)
sites, an indicator of DNA lesion and repair against chemi-
cal damage and cell aging. The assaywas performed accord-
ing to the manufacturer’s instructions.
Cell proliferation assay
Colony formation assays were performed as previously de-
scribed (28). Briefly, cells were seeded and grown in 60 mm
dishes 24 h before treatment with different glucose concen-
trations. The medium in the dishes was changed every 3
days. Cells were then fixed and stained using Coomassie
Brilliant Blue (Biorad, 161–0400). Percent cell growth in-
hibition at each glucose concentration was quantified by
densitometric evaluation using Image J software. For pro-
liferation assays, cells were seeded and grown into 96-well
plates 24 h before treatment. Sulphorhodamine B (S1402,
Sigma) assay (SRB) was carried out as described (29).
Briefly, at the end of incubation, cultures were fixed with
10% trichloroacetic acid and stained with SRB at 0.4%
(w/v) in 1% acetic acid for 30 min. Unbound SRB was
washed out with 1% acetic acid and SRB-bound cells were
solubilized with 10 mM Trizma base (Sigma, T1503). The
absorbance was read at a wavelength of 540 nm using a mi-
croplate reader (BMG Labtech Spectrostar Omega). The
survival fraction was calculated as the ratio of SRB ab-
sorbance of treated cells to SRB absorbance of control cells.
Statistical analysis
The statistical significance of the results was analyzed using
Student’s t-tail test, and a *P-value< 0.05, **P< 0.005 and
***P < 0.001 were considered statistically significant.
RESULTS
The rs2802292 locus has enhancer properties and the presence
of the G-allele creates a unique binding site for HSF1, which
is required for transcriptional activation
To get insight into the role of the rs2802292 G-allele in
the regulation of FOXO3, we first sequenced it in 14 lym-
phoblastoid cell lines established from centenarians and
found that four of themwere homozygous for the rs2802292
T-allele (TT), 7 were heterozygous (TG) and three were ho-
mozygous for the rs2802292 G-allele (GG) (Supplementary
Table S2), thus reflecting the SNPdistribution previously re-
ported in long-lived subjects (13). The intronic localization
of the rs2802292 SNP prompted us to ascertain whether it
could affect regulation of FOXO3 splicing or expression of
alternative starting sites at exon 3. Quantitative RNA anal-
ysis failed to show significant differences in the relative ex-
pression ratio of exon 2 to exon 3 in the three different geno-
types (Figure 1B), indicating that the minor allele (G) does
not influence the assembly of FOXO3 mRNA nor does it
induce an alternative transcription start site. Importantly,
the copy number of the minor G-allele correlated with in-
creased levels of both exon 2 and exon 3 mRNAs, thus con-
firming a transcriptional regulatory role for this region, as
previously hypothesized (21,22) (Figure 1B).
To explore the possibility that the rs2802292 region could
regulate FOXO3 expression, we selected a 90-bp sequence
in intron 2 (bp 108 587 283 to 108 587 372, referred to as
Int2) located around the SNP major allele (T) and cloned
it upstream (5′) to a PGL3-luciferase vector containing the
SV40 promoter sequence (Figure 1A). Based on an in sil-
ico analysis, this sequence comprises transcription factor re-
sponse elements for SP1, GATA1 and ESR1 (Supplemen-
tary Table S3). Preliminary analysis of the transcriptional
ability of the Int2(s)5′-T construct revealed that this se-
quence could be a regulatory region (Figure 1C). Thus, we
also cloned this fragment in the antisense (as) orientation
upstream (5′) to the luciferase gene (Int2(as)5′-T), and in
the sense (Int2(s)3′-T) and antisense (Int2(as)3′-T) orien-
tations downstream (3′) to the luciferase gene (Figure 1A).
All these vectors were able to potently activate transcription
in HEK-293 cells, indicating that this region of intron 2 has
enhancer properties (Figure 1C).
To deepen our understanding of the functional signifi-
cance of the G to T change at genomic position 108 587 315
in the rs2802292 SNP, we carried out an in silico analysis
on this sequence to search for additional transcription fac-
tor response elements and found that the presence of a G
creates a unique binding site for HSF1 (Figure 1D). This
finding prompted us to test the activity of the construct
containing a G (Int2(s)5′-G) instead of a T (Int2(s)5′-T)
at position corresponding to bp 108 587 315 (Figure 1A).
Intriguingly, the Int2(s)5′-G variant significantly enhanced
transcriptional activity compared with the Int2(s)5′-T vec-
tor both in basal conditions and upon HSF1 overexpres-
sion (Figure 1E and Supplementary Figure S1A). More-
over, genetic silencing of HSF1 by two different siRNAs
reduced the activity of the Int2(s)5′-G variant to the lev-
els observed with the Int2(s)5′-T vector, confirming that
endogenous HSF1 is required for enhanced transcriptional
activation (Figure 1F and Supplementary Figure S1B).
HSF1 binds to the genomic rs2802292 enhancer region con-
taining the SNP minor G-allele and induces expression of
FOXO3 in a stress-dependent manner
Consistent with the role of HSF1 in stress resistance, the
Int2(s)5′-G vector was significantly activated by H2O2-
oxidative stress and heat shock in anHSF1-dependentman-
ner (Figure 2A and B; Supplementary Figure S2). Indeed,
the Int2(s)5′-T vector failed to respond to either type of
stress, and genetic silencing (Figure 2A and Supplemen-
tary Figure S2A) or pharmacological inhibition (Figure 2B
and Supplementary Figure S2B) of HSF1 abrogated stress-
dependent Int2(s)5′-G transcriptional activation.
5592 Nucleic Acids Research, 2018, Vol. 46, No. 11
Figure 2. HSF1 binds to the genomic rs2802292 SNP region in cells homozygous for the rs2802292 G-allele and induces the expression of FOXO3 in a
stress-dependent manner. Luciferase reporter assays (n= 3) measuring the effect of HSF1 silencing by siRNA (siHSF1-2) (A) or HSF1 chemical inhibition
(1 h KRIBB11, 10 M) (B) on the enhancer activity of the rs2802292 SNP region upon hydrogen peroxide (1 h H2O2, 100 M) or heat shock (HS) (2
h at 43◦C) treatment. Cells (HEK-293) were collected and analyzed after 2 h of recovery from the indicated treatment. (C) ChIP assays (n = 3) of HSF1
occupancy of the genomic rs2802292 SNP region in HEK-293 cells homozygous for the rs2802292 G-allele (GG) in the presence or absence of exogenous
MYC-tagged-HSF1 with and without H2O2 treatment (1 h, 100 M). (D) ChIP assays (n = 3) testing the effect of HSF1 silencing by siRNA (siHSF1:
siHSF1-2) on HSF1 binding to the genomic rs2802292 SNP region in HEK-293 cells homozygous for the rs2802292 G-allele (GG) and OVCAR-3 cells
homozygous for the rs2802292 T-allele (TT) with and without H2O2 treatment (1 h, 100 M). (E) ChIP analysis (n= 3) of HSF1 occupancy of the genomic
rs2802292 SNP region in homozygous GG and TT cells originated from centenarians upon oxidative (1 h H2O2, 100 M) and glucose restriction (LG)
(10 h, 0.75 mM) stress stimuli. (F) ChIP analysis measuring the effect of LG (10 h, 0.75 mM) on HSF1 occupancy of the genomic rs2802292 SNP region
in additional homozygous GG (n = 3) and TT (n = 3) cells originated from centenarians. (C–F) IgGs were used as an immunoprecipitation control.
Expression levels of FOXO3, HSF1 and HSPA1A protein (G) and FOXO3 and HSPA1A transcript (H) were assessed by immunoblot and qPCR (n = 3),
respectively, in HEK-293 cells homozygous for the rs2802292 G-allele subjected to stress conditions by heat shock (HS) (2 h at 43◦C), hydrogen peroxide
(1 h H2O2, 100 M) and LG (24 h, 0.75 mM). P-values were derived from t-tests: *P ≤ 0.05.
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ChIP analysis revealed that both exogenous MYC-
tagged-HSF1 and endogenous HSF1 could bind to the ge-
nomic rs2802292 SNP region in HEK-293 cells homozy-
gous for the rs2802292 G-allele (GG) (Figure 2C and D),
but not in OVCAR-3 cells homozygous for the rs2802292 T-
allele (TT) (Figure 2C and D). Moreover, binding of HSF1
to the genomic rs2802292 SNP region was strongly induced
by oxidative stress in HEK-293 GG cells, and prevented by
genetic depletion of HSF1 (Figure 2C and D). Similar re-
sults were obtained in GG cells, but not in TT cells, derived
from centenarians (Figure 2E). Furthermore, stress condi-
tions induced by glucose restriction (LG) (30) were also able
to significantly induce HSF1 recruitment at the G-allele in
cells derived from centenarians (Figure 2E). Importantly,
the effect of LG was observed in all GG cells (n = 3), but
not in TT cells (n = 3) (Figure 2F). We next performed a
molecular analysis of homozygous GGHEK-293 cells sub-
jected to cellular stress. Heat shock, H2O2 and LG were all
able to activate HSF1 (Figure 2G) and to induce expression
of the heat shock protein HSPA1A and of FOXO3 both at
the protein and the mRNA level (Figure 2G and H).
Collectively, these results show that cells homozygous for
the minor G-allele (GG) respond to oxidative stress, heat
shock and glucose restriction by activating HSF1, which in
turn binds to the rs2802292 SNP region at the unique HSE
site and induces transcription of FOXO3.
HSF1 mediates the occurrence of a promoter–enhancer in-
teraction at FOXO3 locus involving the 5′UTR and the
rs2802292 region
Enhancers are distal sequences of DNA that can burst tran-
scription of target genes by acting in cis, and their distance
from target promoters may vary from 100 bp to Mb on the
same chromosome (31). These sequences can lie upstream
or downstream of the target gene and even in the gene body
(introns), independently of orientation (32). Furthermore,
enhancer–promoter looping has been shown to be required
for gene activation (33), and chromatin of active enhancers
is ‘marked’ by the combination of H3K4me1/H3K27ac hi-
stone marks (34). Thus, we speculated that the rs2802292-
containing enhancer region could functionally and physi-
cally interact with the FOXO3 promoter under stress con-
ditions in an HSF1-dependent manner. To test this hypoth-
esis, we first performed an in silico analysis of the 5′UTR
region of FOXO3 locus, which revealed the presence of a
putative HSF1 consensus motif at genomic positions 108
553 298–108 553 314 (Figure 3A). This finding prompted
us to ascertain whether HSF1 could be recruited at this ele-
ment while concurrently occupying the rs2802292 enhancer
region in a stress-dependent manner. Our data show that,
upon induction of oxidative stress, HSF1 could efficiently
bind to both regions of FOXO3 locus in HEK-293 cells
(GG) and in human dermal primary fibroblasts that were
homozygous (GG) for the minor G-allele of the rs2802292
SNP (Figure 3B and E). Of note, we failed to detect HSF1
binding at the 5′UTR locus in human primary fibroblasts
that were homozygous (TT) for the major T-allele, even af-
ter H2O2 treatment (Figure 3B and E). This suggests that
HSF1 may bind to these regions in a coordinate manner,
i.e. it can occupy its binding site at the 5′UTR only in cells
where it is bound to the rs2802292 SNP region, which re-
quires the presence of the minor G-allele.
Further characterization of these cells indicated that,
upon induction of oxidative stress, the rs2802292 SNP re-
gion is marked by activating epigenetic modifications typ-
ical of active enhancers involving acetylation of lysine 27
(H3K27ac) and monomethylation of lysine 4 of histone H3
(H3K4me1) only in the presence of the minor G-allele, and
not in TT cells (Figure 3C–E). These data corroborate the
hypothesis that the 5′UTR and the rs2802292 region of
FOXO3 locus may act in cis in stressed cells carrying the
minor G-allele.
Moreover, to address the role of the minor G-allele in
chromatin structural organization and regulation, we first
employed the CRISPR/Cas9 system for genome editing
to generate human near-haploid HAP1 isogenic cell lines:
HAP1FOXO3 SNP rs2802292 (G to T) andHAP1 parental
(G) cells (Supplementary Figure S3). Then, we performed a
ChIP analysis of these cells subjected or not to oxidative
stress. We found that HSF1 could bind to the rs2802292 re-
gion and the 5′UTR site only in HAP1 parental cells, due to
the presence of the G, in a H2O2-dependent manner (Fig-
ure 3B and E). Consistently, also in this isogenic cell sys-
tem, H2O2 induced the H3K27ac and H3K4me1 epigenetic
modifications typical of active enhancers only in the pres-
ence of the minor G-allele (Figure 3C–E). These results
suggest that HSF1 may mediate the occurrence of physi-
cal and functional interactions between the 5′UTR and the
rs2802292 region at FOXO3 locus thereby activating their
enhancer functions.
To further confirm this observation, we performed a
ChIP-loop analysis of HEK-293 cells and primary human
fibroblasts (GG and TT). H2O2-stressed cells were treated
with formaldehyde to obtain cross-linked chromatin, after
which DNA/protein complexes were first digested with the
Csp6I restriction enzyme and then selected with anti-HSF1
antibodies; at last, ligation of chromatin fragments was car-
ried out with the T4 DNA Ligase (Figure 4A). Purified
DNA was analyzed by PCR with primers specific for the
various possible combinations of ligated chromatin frag-
ments (Figure 4B). Our data revealed that HSF1 complexes
mediated the occurrence of a promoter–enhancer interac-
tion involving the 5′UTR and the rs2802292 SNP region
in cells homozygous for the minor G-allele (GG) that were
subjected to oxidative stress (Figure 4B).
Functional studies highlight the importance of the identified
regulatory intronic region in stress response and lifespan reg-
ulation
To determine the impact of the rs2802292 genotype in
stress resistance phenotypes of human primary dermal fi-
broblasts, we treated homozygous GG and TT cells with
H2O2 (or menadione, a potent oxidative stress inducer)
(35) and characterized their oxidative stress response at
different time points during recovery. We first measured
the expression of FOXO3 in these cells and found that its
mRNA levels were significantly increased in an HSF1- and
time-dependent manner only in GG cells (Figure 5A and
Supplementary Figure S4A). Then, we evaluated FOXO3-
dependent transcription in these fibroblasts by transfec-
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Figure 3. HSF1 binds to both the 5′UTR promoter and the rs2802292 SNP enhancer region at FOXO3 locus only in cells containing the minor G-allele
under oxidative stress. (A) Schematic representation of FOXO3 locus revealing the presence of a putative HSF1 consensus motif in the 5′UTR region at
genomic positions 108 553 298–108 553 314. (B–E) ChIP experiments (n = 3) performed on HEK-293 cells homozygous for the rs2802292 G-allele (GG),
homozygous GG and TT cells originated from human dermal primary fibroblasts and HAP1 FOXO3 SNP rs2802292 (G to T) and HAP1 parental (G)
cells cultured in normal conditions and under oxidative stress (1 h H2O2, 100 M) showing HSF1 occupancy of the 5′UTR region and of the genomic
rs2802292 SNP region (B) and the involvement of activating epigenetic modifications such as acetylation of lysine 27 (H3K27ac) (C) and monomethylation
of lysine 4 of histone H3 (H3K4me1) (D) on the 5′UTR and the rs2802292 region in the presence of the minor G-allele, but not in TT cells. IgGs were used
as an immunoprecipitation control (E). Exon 3 region was used as a control. P-values were derived from t-tests: *P ≤ 0.05.
tion of a FOXO3 responsive vector (FHRE-Luc). Our data
showed that stressed GG cells were able to induce sig-
nificantly higher levels of FOXO3 transcriptional activity
than TT fibroblasts in an HSF1-dependent manner (Fig-
ure 5B). These findings were confirmed by analysis of the
expression of FOXO3 endogenous target genes involved in
stress resistance, such as SOD2, CAT,GADD45A, CCND1,
RBL2, BCL2L11 and BCL6. Indeed, stressed GG cells
expressed higher mRNA levels of FOXO3 and its target
genes in an HSF1-dependent manner, while TT fibroblasts
did not (Figure 5F and Supplementary Figure S4B). Of
note, no significant differences were detected between GG
and TT cells when the expression of HSPA1A was ana-
lyzed, thus confirming that the G/T change could influ-
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Figure 4. HSF1 mediates the occurrence of a promoter–enhancer interaction at FOXO3 locus involving the 5′UTR and the rs2802292 region. (A) Top:
physical map of the human FOXO3 gene. The scheme shows the Csp6I restriction enzyme sites flanking the baits (red for the 5′UTR and blue for the
rs2802292 region). Bottom: schematic representation of the 3C and ChIP-loop assay. Crosslinked chromatin was digested with Csp6I and immunopre-
cipitated with anti-HSF1. The immunoprecipitated samples were diluted in a ligation buffer and ligated with the T4 DNA Ligase. After reversing the
crosslinks, the ligated DNA was purified and amplified by PCR with various combinations of primers as indicated in (B). (B) This strategy allows the
amplification of sequences ligated to the bait in circular DNA. The arrows indicate the positions of the primers within the bait sequence. Five different
couples of primers were designed to analyze the five possible ligation products. Purified DNA was analyzed by PCR with primers specific for the various
possible combinations of chromatin fragments. The values are the results of the densitometric analysis and are expressed as fold induction. HEK-293 cells
and primary human fibroblasts (GG, n = 3; TT, n = 3) were collected after induction of oxidative stress (1 h H2O2, 100 M). The presented results are
representative of three independent experiments. P-values were derived from t-tests: *P ≤ 0.05.
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Figure 5. The rs2802292 minor G-allele has a key role in the stress resistance phenotype of human cells. (A–F) Experiments performed on human primary
dermal fibroblasts homozygous for the rs2802292 G-allele (GG, n= 3) or for the rs2802292 T-allele (TT, n= 3) treated with hydrogen peroxide (1 h H2O2,
100 M) in the presence (where indicated) or absence of an HSF1 inhibitor (KRIBB11, 10 M). Cells were collected and analyzed at the indicated time
points during recovery. (A) Expression levels of FOXO3 as measured by qPCR. (B) Evaluation of FOXO3-dependent transcription by transfection of a
FOXO3 responsive vector (FHRE-Luc). Data were obtained by a luciferase reporter assay. (C) Assays performed to measure intracellular ROS levels. (D)
Cellular glutathione assay to measure oxidative stress response. The GSH/GSSG ratio indicates the redox status of the cells and is used as a marker for
oxidative stress. (E) DNA damage quantification assay to measure the level of DNA lesion and repair. AP sites were used as an indicator of DNA damage.
(F) Expression levels of FOXO3 target genes involved in stress resistance (SOD2, CAT, GADD45A, HSPA1A) as measured by qPCR. (G–L) Experiments
performed on HAP1 (T, n= 3) and HAP1 (G, n= 3) cells treated with hydrogen peroxide (1 h H2O2, 100 M) in the presence (where indicated) or absence
of an HSF1 inhibitor (KRIBB11, 10 M). Cells were collected and analyzed at the indicated time points during recovery. (G) Expression levels of FOXO3
as measured by qPCR. (H) Assays performed to measure intracellular ROS levels. (I) Cellular glutathione assay to measure oxidative stress response. (J)
DNA damage quantification assay to measure the level of DNA lesion and repair. (K) Expression levels of FOXO3 target genes involved in stress resistance
(SOD2, CAT, GADD45A, HSPA1A) as measured by qPCR. (L) Immunoblot analysis (left panel) and densitometric analysis after normalization against
the loading control (right panel) of FOXO3 and HSF1 protein expression levels in HAP1 (T) and HAP1 (G) cells at the indicated time points during
recovery from treatment with hydrogen peroxide (1 h H2O2, 100 M). All experiments were repeated three to six times. P-values were derived from t-tests:
P ≤ 0.05: GG relative to GG+KRIBB11. #P≤ 0.05: GG relative to TT. +P ≤ 0.05: GG relative to 0 h time point. *P ≤ 0.05; **P ≤ 0.005; ***P ≤ 0.001.
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ence only FOXO3 transcription and not other HSF1 tar-
get genes (Figure 5F and Supplementary Figure S4A). The
observed stress-dependent upregulation of SOD2 and CAT,
two major antioxidant enzymes involved in ROS detoxi-
fication, prompted us to measure ROS levels in GG ver-
sus TT stressed primary fibroblasts. Our results revealed
that GG cells could very efficiently lower ROS amounts af-
ter stress induction, while TT cells could not (Figure 5C).
Consistently, GG fibroblasts showed a better overall re-
sponse to oxidative stress than TT cells and this response
was HSF1-dependent as shown by the ratio between re-
duced glutathione (GSH) and oxidized glutathione (GSSG)
(Figure 5D). Indeed, after H2O2 withdrawal, GG cells ex-
hibited a significant antioxidant activity lasting for up to 8
h, which was reduced to levels comparable to TT cells upon
pharmacological inhibition of HSF1 (Figure 5D). More-
over, inhibition of HSF1 did not show a significant effect on
TT-cell response (Figure 5D). At last, we quantified DNA
damage by measuring the level of AP sites, an indicator of
DNA lesion and repair against chemical damage and cell
aging, showing that GG cells displayed a significantly bet-
ter DNA repair response (AP site reduction) than TT cells
(Figure 5E).
Then, to further confirm the role of the minor G-allele
in oxidative stress response, we employed the HAP1 iso-
genic cell lines described above.We found that only parental
(G) cells could robustly activate FOXO3 mRNA expres-
sion upon H2O2 exposure (Figure 5G). Moreover, consis-
tent with our previous observations, the presence of the mi-
nor G-allele promoted greater ROS detoxification (Figure
5H), antioxidant activity (GSH/GSSG ratio) (Figure 5I)
and DNA damage repair (measured by AP site reduction)
in cells subjected to oxidative stress (Figure 5J). These re-
sults were corroborated by the upregulation of FOXO3 tar-
get genes involved in stress resistance (SOD2, CAT) and
DNA repair (GADD45A) in an HSF1-dependent manner
(Figure 5K) and specificity was ensured by the analysis of
HSPA1A expression which was independent of the G/T
rs2802292 status (Figure 5K). At last, we performed a pro-
tein analysis of HAP1 FOXO3 SNP rs2802292 (G to T) and
HAP1 parental (G) cells subjected to H2O2 treatment. Ox-
idative stress activated HSF1 in both cell lines, but a robust
and persistent expression of FOXO3 could only be observed
in HAP1 parental (G) cells (Figure 5L).
These data were further supported by the observation
that human GG fibroblasts showed a better survival rate
than TT cells under oxidative stress conditions in short-
term cultures only in the presence of active HSF1 (Sup-
plementary Figure S5). Thus, we decided to extend these
findings by subjecting human primary dermal fibroblasts
(GG versus TT) to different types of chronic stress. First,
we treated GG and TT cells with a 1 h pulse of H2O2 or
menadione followed by 23 h of recovery and repeated this
scheme for up to 5 days. Primary human GG fibroblast
survival fractions remained significantly high (around 70–
80%), while TT cell survival fractions eventually declined
(Figure 6A). Then, we cultured cells under glucose restric-
tion (LG). As shown in Figure 6B, fibroblasts homozygous
for the minor G-allele were able to survive and even pro-
liferate in LG conditions, while TT cells underwent death.
Molecular analysis performed in these cells confirmed LG-
dependent upregulation of FOXO3 and its target genes in-
volved in stress resistance (SOD2, CAT) only in GG cells
(Figure 6C). Moreover we cultured these cells for up to 10
days (Figure 6D and E) or 1 month (Figure 6F and G) un-
der different glucose concentrations (2, 1.5, 1, 0.75 g/l) and
measured both the percentage of growth inhibition (Figure
6D and F) and the survival fraction (Figure 6E andG). Col-
lectively, middle-term (10 days) and long-term (1 month)
culture experiments unequivocally showed that human pri-
mary GG fibroblasts can survive and grow in glucose short-
age conditions, while TT-cell survival was dependent upon
glucose concentration (Figure 6).
Taken together, these results show that GG cells display
a better response to oxidative and metabolic stress than TT
cells, resulting in increased survival under glucose restric-
tion in both middle-term and long-term cultures.
DISCUSSION
Aging is characterized by the accumulation of cellular and
genetic damage throughout life (36). This time-dependent
process is modulated at least in part by exposure to stress
and by the resulting effects on gene expression. Evidence
gathered from fundamental science studies has revealed
that exposure to certain low-intensity or short-term stres-
sors can be beneficial and promote longevity as it enhances
the activity of molecular chaperones and other recovery
mechanisms thereby boosting the stress response of the cell.
Inversely, prolonged or high-intensity stressor exposure is
detrimental and reduces lifespan as it causes increases in
oxidative stress, inflammation, stress hormones and insulin
and can overcome compensatory mechanisms (37).
The use of model organisms has uncovered the exis-
tence of evolutionarily conserved pathways related to aging,
and highlighted that genes regulating endocrine signaling,
stress responses and metabolism can all promote increased
lifespan. Moreover, these studies showed that various age-
related diseases are affected by genes involved in longevity
pathways thus suggesting that a link exists between aging
and disease susceptibility (2). Overall, these findings indi-
cate that longevity is regulated by a complex genetic net-
work governing stress resistance and genomic stability, and
FOXO3 is an important player in this process (38).
Indeed, the minor G-allele of FOXO3 SNP rs2802292 is
strongly associated with longevity in humans (13–19), and
its copy number showed a positive correlation with reduced
age-related disease susceptibility (13). Furthermore a recent
large, prospective cohort study revealed that the strong sur-
vival advantage seen in carriers of the rs2802292 minor G-
allele is associated with a mortality risk reduction for coro-
nary heart disease (CHD). The observation that allelic vari-
ation in FOXO3 affects this risk may have important clini-
cal implications as CHD is the major cause of death in in-
dustrialized countries (39,40). Emerging evidence strongly
suggests that CHD is a manifestation of a chronic inflam-
matory response associated with systemic metabolic per-
turbations leading to cellular and endoplasmic reticulum
stress due to oxidative stress, hypoxia and glucose depri-
vation (41–45). Of note, FOXO3 activity might counteract
all these stressors at both the cellular and systemic level.
Indeed, FOXO3 regulates glucose homeostasis and lipid
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Figure 6. The rs2802292 minor G-allele is involved in lifespan regulation of human cells. (A) Survival fraction of human primary dermal fibroblasts (GG,
n = 3; TT, n = 3). Cells were treated with a pulse of hydrogen peroxide (1 h, 100 M) or menadione (1 h, 20 M) followed by 23 h of recovery for up to 5
days and analyzed at the indicated time points. The effect was determined using the SRB assay. (B) Survival fraction of human primary dermal fibroblasts
(GG, n = 3; TT, n = 3). Cells were cultured in low glucose (LG, 0.75 g/l) and analyzed at the indicated time points. The effect was determined using the
SRB assay. (C) Expression levels of FOXO3 and FOXO3 target genes involved in stress resistance (SOD2, CAT) as measured by qPCR in human primary
dermal fibroblasts (GG, n = 3; TT, n = 3) in middle-term (10 days) culture experiments under high (HG, 2 g/l) or LG (0.75 g/l) conditions. (D and E)
Middle-term (10 days) and (F and G) long-term (1 month) culture experiments on human primary dermal fibroblasts (GG, n = 3; TT, n = 3) grown under
the indicated glucose concentrations. The effect on cell survival is dependent on glucose concentration as shown by colony formation assays (D and F) and
by determination of the survival fraction using the SRB assay (E and G). Cell growth percent inhibition at each glucose concentration is presented in D
and F. All experiments were performed in triplicate and repeated at least three times. Data are expressed as the increase or decrease percentage with respect
to controls (HG). P-values were derived from t-tests: *P ≤ 0.05; **P ≤ 0.005.
metabolism (46–50) in the liver-muscle axis and is an evolu-
tionarily conserved major sensor of endoplasmic reticulum
stress (51,52).
Overall, our results show for the first time that different
types of cellular stresses induce the recruitment of HSF1 on
a uniqueDNAbinding site that is created by the presence of
a G at the FOXO3 intronic SNP rs2802292. This region has
enhancer properties and its activation triggers the upregula-
tion of FOXO3. These data are in agreement with a recent
work conducted by Donlon and colleagues, in which they
provided evidence that, when stimulated by oxidative stress,
the FOXO3 locus could activate several cis-regulating ele-
ments located at intron 2. Moreover, FOXO3 became phys-
ically connected, through chromatin looping, with 46 other
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genes on chromosome 6 thus forming a larger functional
unit that could represent a chromatin domain defining an
aging hub (53). In addition, two intronic FOXO3 SNPs,
one located at intron 2 (rs12206094) and the other at in-
tron 3 (rs4946935), were recently associated with increased
FOXO3 expression and greater transactivation activity in a
luciferase assay (54).
The stress- and HSF1-dependent increase in FOXO3 ex-
pression levels activates its antioxidant and DNA repair
transcriptional program leading to increased tolerance to
stress in short-, middle- and long-term cultures. These find-
ings shed light on the role of FOXO3 rs2802292 minor G-
allele in long-lived subjects and might significantly further
our understanding of themolecularmechanisms involved in
healthy aging and reduced susceptibility to age-related dis-
eases, in particular CHD, diabetes and obesity. Moreover,
we believe that the rs2802292 minor G-allele may serve as
an important predictive marker for prognosis and therapy
response in several conditions triggering oxidative stress re-
sponse in cells and tissues.
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